-
Tophat can do negative values, so put in the actual inner size between fragments, which will be negative if they overlap. -
Tophat paired end read
Hi,
I am analyzing RNA-Seq data from one published paper.
Illumina Hiseq 2000 paired end reads. each end read is 101 bp.
I picked up one pair of reads to check the inner distance (required for Tophat) between these two reads, and found out that these two reads are actually much overlapped.
Then I realized that the size of the selected frangments might be around 133bp, which is why these two paired end reads have overlapping.
In this case, what should we type in for the inner distance between reads when using Tophat? "0" ?
hope you understand my question. Looking forward to hearing from you.Leave a comment:
-
As i am new to Bioinformatics, can anybody explain me single and paired end reads please?.Leave a comment:
-
Tophat paired end read
Hi,
I am analyzing RNA-Seq data from one published paper.
Illumina Hiseq 2000 paired end reads. each end read is 101 bp.
I picked up one pair of reads to check the inner distance (required for Tophat) between these two reads, and found out that these two reads are actually much overlapped.
Then I realized that the size of the selected frangments might be around 133bp, which is why these two paired end reads have overlapping.
In this case, what should we type in for the inner distance between reads when using Tophat? "0" ?
hope you understand my question. Looking forward to hearing from you.
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Leave a comment: